SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-120788
Filing Date
2022-11-21
Accepted
2022-11-21 16:41:41
Documents
2
Group Members
DIALECTIC LIFE SCIENCES SPV LLCDIALECTIC LS MANAGER LLCDIALECTIC PARTNERS, LLCJOHN FICHTHORN

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2230938d2_sc13g.htm SC 13G 66688
2 EXHIBIT 1 tm2230938d2_ex-1.htm EX-99.1 3569
  Complete submission text file 0001104659-22-120788.txt   72268
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Subject) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45969 | Film No.: 221406272
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 119 ROWAYTON AVENUE 2ND FLOOR NORWALK CT 06853
Business Address 119 ROWAYTON AVENUE 2ND FLOOR NORWALK CT 06853 212-230-3220
DIALECTIC CAPITAL MANAGEMENT, LP (Filed by) CIK: 0001411512 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G